Clinical Trial Update: CD19-CAR-T Cells in Patients With R/R B-ALL [Phase 1]

View source ↗

Summary

This Clinical Trial Update describes a Phase 1 study of CD19-CAR-T cells in patients with relapsed/refractory B-cell acute lymphoblastic leukemia. The sponsor i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19 CAR T cells

Snippet

Sponsor: Bioceltech Therapeutics, Ltd. | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 1 | Status: UNKNOWN